| Predoctoral Traineeship Award |
- Principal Investigator: Graduate student enrolled in a PhD or MD/PhD program
- Mentor: Must have breast cancer experience, to include current funding and publications
|
- Supports the training of promising graduate students studying breast cancer research under the guidance of a designated mentor
- The predoctoral trainee is considered the PI and should write the proposal with appropriate direction from the mentor
- Training program should prepare the trainee for an independent career in breast cancer research
|
- Maximum funding of $120K for direct costs (plus indirect costs).
- Period of performance not to exceed 3 years.
|
| Postdoctoral Fellowship Award |
Principal Investigator: Doctoral graduates (PhD or MD)
No more than 2 years in the proposed research setting and no more than 4 years' postdoctoral research experience
Mentor or formal co-mentor: Must have breast cancer experience, to include current funding and publications |
- Supports exceptionally talented recent doctoral graduates who have the ambition and ability to pursue an independent career at the forefront of breast cancer research
- Proposed research should be innovative and have the potential for high impact
- Proposed training and mentorship should facilitate development of the PI as a breast cancer researcher
|
- Maximum funding of $300K for direct costs (plus indirect costs).
- Period of performance not to exceed 3 years.
|
| HBCU/MI Partnership Training Award |
- Principal Investigator/Co-investigator(s): HBCU/MI faculty member with doctoral degree
- Mentor(s): Must have an established breast cancer research program at the mentoring institution
|
- Supports two or more faculty-level investigators at an HBCU/MI to acquire mentored training in breast cancer research
- Supports the establishment of a sustainable breast cancer research program at the applicant HBCU/MI
- Proposed research and training should lead to publication(s) and independent breast cancer research funding
|
- Maximum funding of $1M for direct costs (plus indirect costs).
- Period of performance not to exceed 4 years.
|
| Era of Hope Scholar Award |
Independent, non-mentored investigators within 6 years of their last mentored position as of the nomination deadline
|
- Supports exceptionally talented, creative early-career scientists who have demonstrated that they are the "best and brightest" in their fields
- Individuals should exhibit strong potential for leadership in the breast cancer community
- Nomination letter is required; proposal submission is by invitation only
|
- Maximum funding of $2.5M for direct costs (plus indirect costs).
- Period of performance not to exceed 5 years.
|
| Innovator Award |
Investigators at all academic levels (or equivalent)
|
- Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field
- Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the eradication of breast cancer
- Nomination letter is required; proposal submission is by invitation only
|
- Maximum funding of $5M for direct costs (plus indirect costs).
- Period of performance not to exceed 5 years.
|
| Idea Award |
Investigators at all academic levels (or equivalent)
Postdoctoral-level investigators are eligible to apply
|
- Supports conceptually innovative, high-risk/high-reward research from all areas of basic, translational, clinical, behavioral, and epidemiological research
- Innovation is the most important review criterion
- Preliminary data discouraged, strength of proposal should not rely on preliminary data
- New! Collaborative Option supports combining expertise of two principal investigators to more effectively address an innovative research question
|
- Maximum funding of $375K for direct costs (plus indirect costs). Period of performance not to exceed 2 years.
- For Collaborative Option: Maximum funding of $550K for direct costs (plus indirect costs). Period of performance not to exceed 2 years.
- For Population-Based Studies: Maximum funding of $650K for direct costs (plus indirect costs). Period of performance not to exceed 5 years.
|
| Impact Award |
Investigators at all academic levels (or equivalent)
|
- Supports unique projects that possess strong potential to have a significant impact in breast cancer
- Impact is the most important review criterion (innovation is not a criterion)
- Impact can include advances in basic or clinical research and may be short- or long-term
- Focus on important but understudied issues in breast cancer research such as prevention and risk factors is strongly encouraged
- Preproposal is required; proposal submission is by invitation only
|
- Maximum funding of $2M for direct costs (plus indirect costs).
- Period of performance not to exceed 5 years.
|
| Integrated Multi-Team Research Award |
- Three independent, faculty-level (or equivalent) investigators
- Must include a basic investigator, a clinical investigator, and an investigator from any other area of expertise
|
- Supports three innovative investigators and their research teams in a coordinated and integrated translational research effort to address a question of major importance in breast cancer
- Teams must include consumer advocates
- Multiple institutions must be involved
- A clear plan for intensive collaboration among the teams must be demonstrated
- Regular in-person meetings and on-site cross-training of investigators among the research teams will be required
- Preproposal is required; proposal submission is by invitation only
|
- Maximum funding of $4.5M for direct costs (plus indirect costs).
- Period of performance not to exceed 4 years.
|
